Seres Therapeutics (MCRB) Times Interest Earned (2020 - 2024)
Historic Times Interest Earned for Seres Therapeutics (MCRB) over the last 5 years, with Q1 2024 value amounting to -$55.72.
- Seres Therapeutics' Times Interest Earned fell 5382.63% to -$55.72 in Q1 2024 from the same period last year, while for Dec 2024 it was -$196.3, marking a year-over-year decrease of 88194.47%. This contributed to the annual value of -$79.05 for FY2023, which is 16450.69% down from last year.
- According to the latest figures from Q1 2024, Seres Therapeutics' Times Interest Earned is -$55.72, which was down 5382.63% from $15.54 recorded in Q2 2023.
- Seres Therapeutics' Times Interest Earned's 5-year high stood at $91.94 during Q3 2021, with a 5-year trough of -$66.98 in Q4 2021.
- Moreover, its 5-year median value for Times Interest Earned was -$36.23 (2023), whereas its average is -$28.48.
- Data for Seres Therapeutics' Times Interest Earned shows a peak YoY increase of 32376.99% (in 2021) and a maximum YoY decrease of 18404.63% (in 2021) over the last 5 years.
- Over the past 5 years, Seres Therapeutics' Times Interest Earned (Quarter) stood at -$23.58 in 2020, then crashed by 184.05% to -$66.98 in 2021, then soared by 98.63% to -$0.92 in 2022, then soared by 1787.7% to $15.54 in 2023, then crashed by 458.6% to -$55.72 in 2024.
- Its Times Interest Earned stands at -$55.72 for Q1 2024, versus $15.54 for Q2 2023 and -$36.23 for Q1 2023.